Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58556687 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.58556687 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.21018905 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.21018905 |
5 | protein heterotrimerization (GO:0070208) | 6.99598079 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 6.78599411 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17006274 |
8 | tryptophan catabolic process (GO:0006569) | 6.13109447 |
9 | indole-containing compound catabolic process (GO:0042436) | 6.13109447 |
10 | indolalkylamine catabolic process (GO:0046218) | 6.13109447 |
11 | kynurenine metabolic process (GO:0070189) | 6.04175525 |
12 | bile acid biosynthetic process (GO:0006699) | 5.98631792 |
13 | tryptophan metabolic process (GO:0006568) | 5.74353029 |
14 | urea metabolic process (GO:0019627) | 5.61904022 |
15 | urea cycle (GO:0000050) | 5.61904022 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60225930 |
17 | glyoxylate metabolic process (GO:0046487) | 5.59117763 |
18 | negative regulation of fibrinolysis (GO:0051918) | 5.56873372 |
19 | complement activation, alternative pathway (GO:0006957) | 5.46015606 |
20 | regulation of protein activation cascade (GO:2000257) | 5.39316706 |
21 | regulation of fibrinolysis (GO:0051917) | 5.39146909 |
22 | protein carboxylation (GO:0018214) | 5.38498683 |
23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38498683 |
24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.38192936 |
25 | cysteine metabolic process (GO:0006534) | 5.28158251 |
26 | sulfur amino acid catabolic process (GO:0000098) | 5.26037921 |
27 | collagen fibril organization (GO:0030199) | 5.19697738 |
28 | nitrogen cycle metabolic process (GO:0071941) | 5.15400726 |
29 | bile acid metabolic process (GO:0008206) | 5.11863064 |
30 | regulation of complement activation (GO:0030449) | 5.05041011 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.98082880 |
32 | aromatic amino acid family metabolic process (GO:0009072) | 4.88859379 |
33 | arginine catabolic process (GO:0006527) | 4.84847600 |
34 | tyrosine metabolic process (GO:0006570) | 4.78733851 |
35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78631150 |
36 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.76911792 |
37 | homocysteine metabolic process (GO:0050667) | 4.71846166 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.70757816 |
39 | reverse cholesterol transport (GO:0043691) | 4.66983464 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.64592683 |
41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59788854 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.59788854 |
43 | macromolecular complex remodeling (GO:0034367) | 4.59788854 |
44 | triglyceride homeostasis (GO:0070328) | 4.57721023 |
45 | acylglycerol homeostasis (GO:0055090) | 4.57721023 |
46 | alpha-amino acid catabolic process (GO:1901606) | 4.57431311 |
47 | amino-acid betaine metabolic process (GO:0006577) | 4.55741726 |
48 | lysine metabolic process (GO:0006553) | 4.49126704 |
49 | lysine catabolic process (GO:0006554) | 4.49126704 |
50 | cellular ketone body metabolic process (GO:0046950) | 4.42444319 |
51 | negative regulation of sterol transport (GO:0032372) | 4.38801676 |
52 | negative regulation of cholesterol transport (GO:0032375) | 4.38801676 |
53 | coenzyme catabolic process (GO:0009109) | 4.37928526 |
54 | phospholipid efflux (GO:0033700) | 4.36178683 |
55 | bile acid and bile salt transport (GO:0015721) | 4.35146194 |
56 | indolalkylamine metabolic process (GO:0006586) | 4.33003899 |
57 | plasma lipoprotein particle clearance (GO:0034381) | 4.26669198 |
58 | cellular glucuronidation (GO:0052695) | 4.25919092 |
59 | glutamate metabolic process (GO:0006536) | 4.24118202 |
60 | imidazole-containing compound metabolic process (GO:0052803) | 4.22683607 |
61 | cellular amino acid catabolic process (GO:0009063) | 4.21986106 |
62 | cellular biogenic amine catabolic process (GO:0042402) | 4.19239550 |
63 | amine catabolic process (GO:0009310) | 4.19239550 |
64 | diaphragm development (GO:0060539) | 4.16519323 |
65 | glycine metabolic process (GO:0006544) | 4.13884794 |
66 | benzene-containing compound metabolic process (GO:0042537) | 4.08081912 |
67 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07841815 |
68 | cholesterol efflux (GO:0033344) | 4.07391431 |
69 | cellular modified amino acid catabolic process (GO:0042219) | 4.03958585 |
70 | endodermal cell differentiation (GO:0035987) | 4.01871867 |
71 | serine family amino acid metabolic process (GO:0009069) | 3.99646428 |
72 | ethanol oxidation (GO:0006069) | 3.97349731 |
73 | cell migration involved in heart development (GO:0060973) | 3.94841174 |
74 | fibrinolysis (GO:0042730) | 3.94224123 |
75 | arginine metabolic process (GO:0006525) | 3.93473375 |
76 | muscle filament sliding (GO:0030049) | 3.90818205 |
77 | actin-myosin filament sliding (GO:0033275) | 3.90818205 |
78 | actin-mediated cell contraction (GO:0070252) | 3.90259772 |
79 | negative regulation of vascular permeability (GO:0043116) | 3.88582635 |
80 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.88415063 |
81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.84315449 |
82 | myoblast fusion (GO:0007520) | 3.83517052 |
83 | kidney mesenchyme development (GO:0072074) | 3.83470413 |
84 | ketone body metabolic process (GO:1902224) | 3.81853153 |
85 | positive regulation of lipid catabolic process (GO:0050996) | 3.80191157 |
86 | complement activation, classical pathway (GO:0006958) | 3.78719860 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 3.77975082 |
88 | cytolysis (GO:0019835) | 3.77718979 |
89 | complement activation (GO:0006956) | 3.77675733 |
90 | serine family amino acid biosynthetic process (GO:0009070) | 3.76665141 |
91 | uronic acid metabolic process (GO:0006063) | 3.76643437 |
92 | glucuronate metabolic process (GO:0019585) | 3.76643437 |
93 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.76214151 |
94 | drug catabolic process (GO:0042737) | 3.75510656 |
95 | extracellular matrix assembly (GO:0085029) | 3.75309110 |
96 | negative regulation of lipase activity (GO:0060192) | 3.72755246 |
97 | aldehyde catabolic process (GO:0046185) | 3.72366280 |
98 | skeletal muscle organ development (GO:0060538) | 3.70764455 |
99 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70645264 |
100 | cofactor catabolic process (GO:0051187) | 3.69695934 |
101 | protein activation cascade (GO:0072376) | 3.68808240 |
102 | regulation of cholesterol homeostasis (GO:2000188) | 3.68716125 |
103 | carboxylic acid catabolic process (GO:0046395) | 3.68622342 |
104 | organic acid catabolic process (GO:0016054) | 3.68622342 |
105 | acetyl-CoA metabolic process (GO:0006084) | 3.67222533 |
106 | phospholipid homeostasis (GO:0055091) | 3.66784785 |
107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66155092 |
108 | chondrocyte proliferation (GO:0035988) | 3.65762460 |
109 | short-chain fatty acid metabolic process (GO:0046459) | 3.65460387 |
110 | cholesterol homeostasis (GO:0042632) | 3.63024847 |
111 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.61742233 |
112 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.61653543 |
113 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.61238223 |
114 | bone trabecula formation (GO:0060346) | 3.60856869 |
115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59687059 |
116 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.58599522 |
117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58341799 |
118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58341799 |
119 | sterol homeostasis (GO:0055092) | 3.57194544 |
120 | negative regulation of protein activation cascade (GO:2000258) | 3.54843238 |
121 | positive regulation of catecholamine secretion (GO:0033605) | 3.54188279 |
122 | opsonization (GO:0008228) | 3.53120086 |
123 | extracellular fibril organization (GO:0043206) | 3.50870896 |
124 | plasma lipoprotein particle organization (GO:0071827) | 3.46125354 |
125 | cellular response to vitamin (GO:0071295) | 3.40063869 |
126 | metanephric mesenchyme development (GO:0072075) | 3.38271504 |
127 | adhesion of symbiont to host cell (GO:0044650) | 3.30576052 |
128 | virion attachment to host cell (GO:0019062) | 3.30576052 |
129 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.30381775 |
130 | type B pancreatic cell proliferation (GO:0044342) | 3.29011197 |
131 | negative regulation of neurotransmitter transport (GO:0051589) | 3.27832087 |
132 | regulation of skeletal muscle contraction (GO:0014819) | 3.27335550 |
133 | establishment of tissue polarity (GO:0007164) | 3.25980314 |
134 | establishment of planar polarity (GO:0001736) | 3.25980314 |
135 | regulation of the force of heart contraction (GO:0002026) | 3.21078398 |
136 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.19201129 |
137 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.18327737 |
138 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.15813987 |
139 | hypotonic response (GO:0006971) | 3.15303307 |
140 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.14959373 |
141 | negative regulation of protein localization to cell surface (GO:2000009) | 3.13798736 |
142 | cellular response to vitamin D (GO:0071305) | 3.12779028 |
143 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.09361332 |
144 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.07327202 |
145 | dermatan sulfate biosynthetic process (GO:0030208) | 3.06709629 |
146 | response to gravity (GO:0009629) | 3.04969357 |
147 | lymphangiogenesis (GO:0001946) | 3.04412435 |
148 | blood vessel maturation (GO:0001955) | 3.03692157 |
149 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.00260763 |
150 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.96625503 |
151 | syncytium formation (GO:0006949) | 2.96194104 |
152 | dermatan sulfate metabolic process (GO:0030205) | 2.94395431 |
153 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.93149889 |
154 | muscle cell fate commitment (GO:0042693) | 2.88994054 |
155 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.87594058 |
156 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.87332420 |
157 | UMP metabolic process (GO:0046049) | 2.87332420 |
158 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.87332420 |
159 | UMP biosynthetic process (GO:0006222) | 2.87332420 |
160 | skin morphogenesis (GO:0043589) | 2.84821950 |
161 | fibril organization (GO:0097435) | 2.83271726 |
162 | extracellular regulation of signal transduction (GO:1900115) | 2.82879715 |
163 | extracellular negative regulation of signal transduction (GO:1900116) | 2.82879715 |
164 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.82242506 |
165 | axon extension involved in axon guidance (GO:0048846) | 2.82242506 |
166 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.80653219 |
167 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.79554878 |
168 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.78935489 |
169 | lateral sprouting from an epithelium (GO:0060601) | 2.78920178 |
170 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.77557226 |
171 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.77380248 |
172 | regulation of neurotransmitter uptake (GO:0051580) | 2.76680825 |
173 | endocardial cushion development (GO:0003197) | 2.75978317 |
174 | collagen metabolic process (GO:0032963) | 2.75972131 |
175 | cell adhesion mediated by integrin (GO:0033627) | 2.75750475 |
176 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.74824480 |
177 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.71451898 |
178 | actin filament-based movement (GO:0030048) | 2.71141143 |
179 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.70825201 |
180 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.69467232 |
181 | muscle organ development (GO:0007517) | 2.68933199 |
182 | muscle structure development (GO:0061061) | 2.68234257 |
183 | negative regulation of axon guidance (GO:1902668) | 2.65500473 |
184 | collagen catabolic process (GO:0030574) | 2.64262161 |
185 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.63869432 |
186 | adhesion of symbiont to host (GO:0044406) | 2.62289579 |
187 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.61958618 |
188 | negative regulation of BMP signaling pathway (GO:0030514) | 2.60862767 |
189 | smooth muscle tissue development (GO:0048745) | 2.60383639 |
190 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.58623567 |
191 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.56826488 |
192 | relaxation of smooth muscle (GO:0044557) | 2.52792694 |
193 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.52477482 |
194 | substrate-dependent cell migration (GO:0006929) | 2.51949483 |
195 | cardiac myofibril assembly (GO:0055003) | 2.51752406 |
196 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.51482363 |
197 | actin filament depolymerization (GO:0030042) | 2.49984641 |
198 | negative regulation of potassium ion transport (GO:0043267) | 2.48591702 |
199 | positive regulation of axon extension (GO:0045773) | 2.48584686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.94850069 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.71248331 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54314130 |
4 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.52160319 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17170295 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.01692740 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72335579 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.57453390 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98991546 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.52599824 |
11 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.72460849 |
12 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.56049806 |
13 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.47431679 |
14 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.43858941 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.36488851 |
16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13516972 |
17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.13011854 |
18 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.11950496 |
19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.07668715 |
20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01563921 |
21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01441878 |
22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00837818 |
23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2781173 |
24 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97981830 |
25 | TP53_16413492_ChIP-PET_HCT116_Human | 1.96069327 |
26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84483095 |
27 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.84293542 |
28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.83697021 |
29 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.82232337 |
30 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.79852999 |
31 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.78813985 |
32 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.71939120 |
33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70765105 |
34 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.70365828 |
35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70222616 |
36 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67630351 |
37 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.64989718 |
38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64704054 |
39 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64117703 |
40 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.62247967 |
41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58513646 |
42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57755373 |
43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54910430 |
44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.51548680 |
45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48995023 |
46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48685598 |
47 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43864007 |
48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41650190 |
49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41650190 |
50 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.41510847 |
51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34823217 |
52 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.33420355 |
53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31801241 |
54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31348984 |
55 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.31006438 |
56 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28609564 |
57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28527825 |
58 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.26193823 |
59 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.24396710 |
60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24126424 |
61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23988293 |
62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22923277 |
63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20942987 |
64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20880409 |
65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20470802 |
66 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19813845 |
67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17845757 |
68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16971550 |
69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16690907 |
70 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16008791 |
71 | JUN_21703547_ChIP-Seq_K562_Human | 1.15703978 |
72 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14742892 |
73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14627864 |
74 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14603382 |
75 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.14598368 |
76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11795936 |
77 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11701014 |
78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11088299 |
79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10999849 |
80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10414555 |
81 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.10292216 |
82 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09030925 |
83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07346124 |
84 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.05270174 |
85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04469373 |
86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03400579 |
87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02799711 |
88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02745495 |
89 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01896492 |
90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01621815 |
91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01068893 |
92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00332748 |
93 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99809231 |
94 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99607164 |
95 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.98807470 |
96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98478748 |
97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98286027 |
98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98275777 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98248919 |
100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98132078 |
101 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.96028515 |
102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95984007 |
103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95984007 |
104 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95917705 |
105 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.95609786 |
106 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.95584602 |
107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94436691 |
108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94330268 |
109 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.93600423 |
110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93198653 |
111 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92999934 |
112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92984772 |
113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92984772 |
114 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92904500 |
115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92736536 |
116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92566450 |
117 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92188571 |
118 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91446100 |
119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89826130 |
120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84141749 |
121 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79143066 |
122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76759634 |
123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.76005014 |
124 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75711841 |
125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73520050 |
126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72954535 |
127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71605439 |
128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70169546 |
129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69749552 |
130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69436569 |
131 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69258004 |
132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68765454 |
133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67857535 |
134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66620711 |
135 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.66342329 |
136 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65342909 |
137 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.62898587 |
138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60328028 |
139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.60205088 |
140 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.59873020 |
141 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58850467 |
142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56188793 |
143 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55966091 |
144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55524809 |
145 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55062872 |
146 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.54837826 |
147 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54045558 |
148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51945240 |
149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.51908296 |
150 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51539096 |
151 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50124504 |
152 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.49513470 |
153 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49018130 |
154 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48259600 |
155 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.47906317 |
156 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.47013635 |
157 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46967048 |
158 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.46601153 |
159 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.46358635 |
160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.45756344 |
161 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.45564834 |
162 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45422947 |
163 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44792058 |
164 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44428375 |
165 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44368677 |
166 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.44065099 |
167 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43356311 |
168 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.42859129 |
169 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.42602092 |
170 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42369686 |
171 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.42279304 |
172 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41794158 |
173 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41434307 |
174 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.41371223 |
175 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41086644 |
176 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.40100723 |
177 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.38690838 |
178 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.38534804 |
179 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38338599 |
180 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.38011619 |
181 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.37654610 |
182 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37146658 |
183 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.37040619 |
184 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36958396 |
185 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36773162 |
186 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.36558483 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.30728692 |
2 | MP0005360_urolithiasis | 7.63043125 |
3 | MP0008438_abnormal_cutaneous_collagen | 6.53617969 |
4 | MP0005085_abnormal_gallbladder_physiolo | 6.46779449 |
5 | MP0005365_abnormal_bile_salt | 6.17761739 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15027814 |
7 | MP0003806_abnormal_nucleotide_metabolis | 4.06508118 |
8 | MP0003252_abnormal_bile_duct | 3.93313890 |
9 | MP0003279_aneurysm | 3.71307683 |
10 | MP0005503_abnormal_tendon_morphology | 3.71061898 |
11 | MP0010329_abnormal_lipoprotein_level | 3.69979907 |
12 | MP0003646_muscle_fatigue | 3.62575646 |
13 | MP0001958_emphysema | 3.13971560 |
14 | MP0009840_abnormal_foam_cell | 3.05104716 |
15 | MP0002234_abnormal_pharynx_morphology | 2.98073791 |
16 | MP0005083_abnormal_biliary_tract | 2.96355000 |
17 | MP0003950_abnormal_plasma_membrane | 2.93535674 |
18 | MP0005275_abnormal_skin_tensile | 2.90085615 |
19 | MP0004084_abnormal_cardiac_muscle | 2.90047864 |
20 | MP0005332_abnormal_amino_acid | 2.68784565 |
21 | MP0003195_calcinosis | 2.67543739 |
22 | MP0004272_abnormal_basement_membrane | 2.67469562 |
23 | MP0001666_abnormal_nutrient_absorption | 2.51349978 |
24 | MP0004233_abnormal_muscle_weight | 2.49458402 |
25 | MP0006054_spinal_hemorrhage | 2.46284829 |
26 | MP0003191_abnormal_cellular_cholesterol | 2.34121807 |
27 | MP0001542_abnormal_bone_strength | 2.30773004 |
28 | MP0005623_abnormal_meninges_morphology | 2.27568949 |
29 | MP0000751_myopathy | 2.23442750 |
30 | MP0000749_muscle_degeneration | 2.17073423 |
31 | MP0002118_abnormal_lipid_homeostasis | 2.13522630 |
32 | MP0004036_abnormal_muscle_relaxation | 2.10944408 |
33 | MP0004858_abnormal_nervous_system | 2.10757136 |
34 | MP0000609_abnormal_liver_physiology | 2.09512957 |
35 | MP0003283_abnormal_digestive_organ | 2.09094220 |
36 | MP0000767_abnormal_smooth_muscle | 2.02845063 |
37 | MP0004019_abnormal_vitamin_homeostasis | 2.02682025 |
38 | MP0005257_abnormal_intraocular_pressure | 2.02114129 |
39 | MP0003868_abnormal_feces_composition | 1.89686011 |
40 | MP0000013_abnormal_adipose_tissue | 1.88997460 |
41 | MP0000733_abnormal_muscle_development | 1.84793548 |
42 | MP0003566_abnormal_cell_adhesion | 1.84604902 |
43 | MP0004043_abnormal_pH_regulation | 1.75271906 |
44 | MP0005319_abnormal_enzyme/_coenzyme | 1.73801261 |
45 | MP0010030_abnormal_orbit_morphology | 1.72005860 |
46 | MP0001879_abnormal_lymphatic_vessel | 1.70537766 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.70155748 |
48 | MP0005508_abnormal_skeleton_morphology | 1.68369544 |
49 | MP0009697_abnormal_copulation | 1.63507630 |
50 | MP0001764_abnormal_homeostasis | 1.62700860 |
51 | MP0002108_abnormal_muscle_morphology | 1.61770055 |
52 | MP0009250_abnormal_appendicular_skeleto | 1.58722798 |
53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55904860 |
54 | MP0008775_abnormal_heart_ventricle | 1.48169643 |
55 | MP0010386_abnormal_urinary_bladder | 1.45914943 |
56 | MP0000759_abnormal_skeletal_muscle | 1.43960527 |
57 | MP0000750_abnormal_muscle_regeneration | 1.43170127 |
58 | MP0004145_abnormal_muscle_electrophysio | 1.41155924 |
59 | MP0003705_abnormal_hypodermis_morpholog | 1.41001995 |
60 | MP0003091_abnormal_cell_migration | 1.40450540 |
61 | MP0000534_abnormal_ureter_morphology | 1.38080654 |
62 | MP0005620_abnormal_muscle_contractility | 1.34195608 |
63 | MP0003011_delayed_dark_adaptation | 1.30545348 |
64 | MP0005451_abnormal_body_composition | 1.25648281 |
65 | MP0003045_fibrosis | 1.25358803 |
66 | MP0005171_absent_coat_pigmentation | 1.23831291 |
67 | MP0004134_abnormal_chest_morphology | 1.16959680 |
68 | MP0002896_abnormal_bone_mineralization | 1.16209905 |
69 | MP0000163_abnormal_cartilage_morphology | 1.16083186 |
70 | MP0001299_abnormal_eye_distance/ | 1.14889089 |
71 | MP0005023_abnormal_wound_healing | 1.13998474 |
72 | MP0005647_abnormal_sex_gland | 1.13654710 |
73 | MP0003942_abnormal_urinary_system | 1.11539338 |
74 | MP0009643_abnormal_urine_homeostasis | 1.10297625 |
75 | MP0005369_muscle_phenotype | 1.10177813 |
76 | MP0000604_amyloidosis | 1.08788668 |
77 | MP0000598_abnormal_liver_morphology | 1.08664004 |
78 | MP0003186_abnormal_redox_activity | 1.06974417 |
79 | MP0003656_abnormal_erythrocyte_physiolo | 1.06368443 |
80 | MP0002106_abnormal_muscle_physiology | 1.05811554 |
81 | MP0005645_abnormal_hypothalamus_physiol | 1.05703210 |
82 | MP0010368_abnormal_lymphatic_system | 1.03356942 |
83 | MP0002254_reproductive_system_inflammat | 1.02167231 |
84 | MP0002876_abnormal_thyroid_physiology | 1.00808583 |
85 | MP0000566_synostosis | 1.00259896 |
86 | MP0006138_congestive_heart_failure | 0.99457120 |
87 | MP0002127_abnormal_cardiovascular_syste | 0.98288085 |
88 | MP0005197_abnormal_uvea_morphology | 0.97291709 |
89 | MP0009764_decreased_sensitivity_to | 0.96887595 |
90 | MP0002233_abnormal_nose_morphology | 0.96557163 |
91 | MP0009763_increased_sensitivity_to | 0.96177250 |
92 | MP0002115_abnormal_skeleton_extremities | 0.94308218 |
93 | MP0000428_abnormal_craniofacial_morphol | 0.93600182 |
94 | MP0005670_abnormal_white_adipose | 0.92963124 |
95 | MP0005390_skeleton_phenotype | 0.91719460 |
96 | MP0002113_abnormal_skeleton_development | 0.91692908 |
97 | MP0006082_CNS_inflammation | 0.90294439 |
98 | MP0001661_extended_life_span | 0.89270199 |
99 | MP0004087_abnormal_muscle_fiber | 0.88599265 |
100 | MP0002128_abnormal_blood_circulation | 0.86987380 |
101 | MP0003937_abnormal_limbs/digits/tail_de | 0.86732603 |
102 | MP0000467_abnormal_esophagus_morphology | 0.86326915 |
103 | MP0002109_abnormal_limb_morphology | 0.85068135 |
104 | MP0002972_abnormal_cardiac_muscle | 0.84834541 |
105 | MP0004130_abnormal_muscle_cell | 0.84725510 |
106 | MP0000049_abnormal_middle_ear | 0.84074834 |
107 | MP0002116_abnormal_craniofacial_bone | 0.83488351 |
108 | MP0002971_abnormal_brown_adipose | 0.83303817 |
109 | MP0005167_abnormal_blood-brain_barrier | 0.82482788 |
110 | MP0005636_abnormal_mineral_homeostasis | 0.81625469 |
111 | MP0009642_abnormal_blood_homeostasis | 0.81545153 |
112 | MP0002078_abnormal_glucose_homeostasis | 0.80872064 |
113 | MP0004484_altered_response_of | 0.80577076 |
114 | MP0000538_abnormal_urinary_bladder | 0.80483775 |
115 | MP0003755_abnormal_palate_morphology | 0.79279635 |
116 | MP0005535_abnormal_body_temperature | 0.78680946 |
117 | MP0000432_abnormal_head_morphology | 0.78418089 |
118 | MP0009053_abnormal_anal_canal | 0.78319954 |
119 | MP0005084_abnormal_gallbladder_morpholo | 0.77815767 |
120 | MP0000639_abnormal_adrenal_gland | 0.77680631 |
121 | MP0002932_abnormal_joint_morphology | 0.77508719 |
122 | MP0005376_homeostasis/metabolism_phenot | 0.76838474 |
123 | MP0005334_abnormal_fat_pad | 0.76733630 |
124 | MP0003329_amyloid_beta_deposits | 0.74199743 |
125 | MP0006036_abnormal_mitochondrial_physio | 0.73289614 |
126 | MP0005408_hypopigmentation | 0.73241203 |
127 | MP0002332_abnormal_exercise_endurance | 0.72983045 |
128 | MP0008469_abnormal_protein_level | 0.72746583 |
129 | MP0003690_abnormal_glial_cell | 0.71618972 |
130 | MP0003385_abnormal_body_wall | 0.70425777 |
131 | MP0001664_abnormal_digestion | 0.69934735 |
132 | MP0009765_abnormal_xenobiotic_induced | 0.68285539 |
133 | MP0005220_abnormal_exocrine_pancreas | 0.67791907 |
134 | MP0002282_abnormal_trachea_morphology | 0.65147749 |
135 | MP0005448_abnormal_energy_balance | 0.64803832 |
136 | MP0002114_abnormal_axial_skeleton | 0.63846540 |
137 | MP0001544_abnormal_cardiovascular_syste | 0.63638488 |
138 | MP0005385_cardiovascular_system_phenoty | 0.63638488 |
139 | MP0004133_heterotaxia | 0.63018132 |
140 | MP0002837_dystrophic_cardiac_calcinosis | 0.62942181 |
141 | MP0000762_abnormal_tongue_morphology | 0.62548673 |
142 | MP0002822_catalepsy | 0.62379111 |
143 | MP0005266_abnormal_metabolism | 0.61813448 |
144 | MP0000747_muscle_weakness | 0.61519318 |
145 | MP0002269_muscular_atrophy | 0.60120358 |
146 | MP0000003_abnormal_adipose_tissue | 0.58527857 |
147 | MP0005248_abnormal_Harderian_gland | 0.58364405 |
148 | MP0003941_abnormal_skin_development | 0.57705374 |
149 | MP0001756_abnormal_urination | 0.56232018 |
150 | MP0006035_abnormal_mitochondrial_morpho | 0.55767215 |
151 | MP0008874_decreased_physiological_sensi | 0.54557107 |
152 | MP0005666_abnormal_adipose_tissue | 0.51122683 |
153 | MP0003638_abnormal_response/metabolism_ | 0.48654421 |
154 | MP0009384_cardiac_valve_regurgitation | 0.46373383 |
155 | MP0005187_abnormal_penis_morphology | 0.44616137 |
156 | MP0000579_abnormal_nail_morphology | 0.44472624 |
157 | MP0005395_other_phenotype | 0.43712986 |
158 | MP0003953_abnormal_hormone_level | 0.42410386 |
159 | MP0008872_abnormal_physiological_respon | 0.41988108 |
160 | MP0009115_abnormal_fat_cell | 0.41149045 |
161 | MP0002168_other_aberrant_phenotype | 0.39750038 |
162 | MP0002928_abnormal_bile_duct | 0.38866941 |
163 | MP0003075_altered_response_to | 0.37807947 |
164 | MP0004883_abnormal_blood_vessel | 0.36801400 |
165 | MP0000230_abnormal_systemic_arterial | 0.36570216 |
166 | MP0009672_abnormal_birth_weight | 0.36156453 |
167 | MP0000427_abnormal_hair_cycle | 0.36144614 |
168 | MP0008873_increased_physiological_sensi | 0.35696409 |
169 | MP0002090_abnormal_vision | 0.35078172 |
170 | MP0002970_abnormal_white_adipose | 0.34688433 |
171 | MP0003724_increased_susceptibility_to | 0.34171263 |
172 | MP0005166_decreased_susceptibility_to | 0.32925855 |
173 | MP0004782_abnormal_surfactant_physiolog | 0.32860882 |
174 | MP0002136_abnormal_kidney_physiology | 0.32486394 |
175 | MP0005595_abnormal_vascular_smooth | 0.31821478 |
176 | MP0004381_abnormal_hair_follicle | 0.31589215 |
177 | MP0005464_abnormal_platelet_physiology | 0.30619690 |
178 | MP0001243_abnormal_dermal_layer | 0.29715760 |
179 | MP0003959_abnormal_lean_body | 0.28229736 |
180 | MP0002060_abnormal_skin_morphology | 0.28030374 |
181 | MP0001881_abnormal_mammary_gland | 0.27907504 |
182 | MP0005164_abnormal_response_to | 0.27565529 |
183 | MP0002796_impaired_skin_barrier | 0.27142399 |
184 | MP0002295_abnormal_pulmonary_circulatio | 0.26682414 |
185 | MP0000249_abnormal_blood_vessel | 0.26285611 |
186 | MP0009780_abnormal_chondrocyte_physiolo | 0.23334463 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.66232685 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.41221894 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.38304509 |
4 | Premature rupture of membranes (HP:0001788) | 6.87234997 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.65596885 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.58698249 |
7 | Hypobetalipoproteinemia (HP:0003563) | 6.37240724 |
8 | Xanthomatosis (HP:0000991) | 6.29850375 |
9 | Type 1 muscle fiber predominance (HP:0003803) | 6.26386153 |
10 | Protrusio acetabuli (HP:0003179) | 6.13292506 |
11 | Hyperlipoproteinemia (HP:0010980) | 5.69519506 |
12 | Complement deficiency (HP:0004431) | 5.67166357 |
13 | Hypolipoproteinemia (HP:0010981) | 4.79893379 |
14 | Aortic aneurysm (HP:0004942) | 4.79007002 |
15 | Epidermoid cyst (HP:0200040) | 4.73614867 |
16 | Joint hemorrhage (HP:0005261) | 4.67209540 |
17 | Nemaline bodies (HP:0003798) | 4.64036316 |
18 | Aortic dissection (HP:0002647) | 4.58656544 |
19 | Hyperammonemia (HP:0001987) | 4.57017240 |
20 | Ankle contracture (HP:0006466) | 4.54955923 |
21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54610041 |
22 | Hyperglycinemia (HP:0002154) | 4.43338608 |
23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.40935436 |
24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40626647 |
25 | Muscle fiber inclusion bodies (HP:0100299) | 4.34455095 |
26 | Abnormality of methionine metabolism (HP:0010901) | 4.29989910 |
27 | Ketosis (HP:0001946) | 4.25807301 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 4.24099522 |
29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23134532 |
30 | Neonatal short-limb short stature (HP:0008921) | 4.17148359 |
31 | Follicular hyperkeratosis (HP:0007502) | 4.15667845 |
32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.12343768 |
33 | Fat malabsorption (HP:0002630) | 4.09147651 |
34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08675663 |
35 | Abnormality of complement system (HP:0005339) | 4.08542895 |
36 | Soft skin (HP:0000977) | 4.03190477 |
37 | Slender build (HP:0001533) | 3.96386413 |
38 | Abnormality of glycine metabolism (HP:0010895) | 3.88867964 |
39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88867964 |
40 | Spinal rigidity (HP:0003306) | 3.88633856 |
41 | Hyperglycinuria (HP:0003108) | 3.85865299 |
42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77453512 |
43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.76774583 |
44 | Hypoglycemic coma (HP:0001325) | 3.73831731 |
45 | Hypercholesterolemia (HP:0003124) | 3.68439056 |
46 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56849547 |
47 | Vascular tortuosity (HP:0004948) | 3.52329831 |
48 | Bladder diverticulum (HP:0000015) | 3.41627993 |
49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36533903 |
50 | Round ear (HP:0100830) | 3.32298001 |
51 | Delayed CNS myelination (HP:0002188) | 3.27773741 |
52 | Abnormality of dentin (HP:0010299) | 3.26929448 |
53 | Hyperbilirubinemia (HP:0002904) | 3.26700749 |
54 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24755817 |
55 | Popliteal pterygium (HP:0009756) | 3.21426367 |
56 | Spontaneous abortion (HP:0005268) | 3.17313890 |
57 | Steatorrhea (HP:0002570) | 3.08754316 |
58 | Abnormality of serum amino acid levels (HP:0003112) | 3.04886743 |
59 | Genu recurvatum (HP:0002816) | 3.03373943 |
60 | Ketoacidosis (HP:0001993) | 3.03301601 |
61 | Blue sclerae (HP:0000592) | 3.01508331 |
62 | Skin nodule (HP:0200036) | 2.93107538 |
63 | Myocardial infarction (HP:0001658) | 2.92146516 |
64 | Hypochromic microcytic anemia (HP:0004840) | 2.91371517 |
65 | Atrophic scars (HP:0001075) | 2.90992695 |
66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.88942644 |
67 | Hepatocellular carcinoma (HP:0001402) | 2.87308677 |
68 | Peritonitis (HP:0002586) | 2.85380749 |
69 | Sparse lateral eyebrow (HP:0005338) | 2.82336201 |
70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.81761729 |
71 | Shallow orbits (HP:0000586) | 2.79488815 |
72 | Increased variability in muscle fiber diameter (HP:0003557) | 2.78775878 |
73 | Ulnar deviation of the wrist (HP:0003049) | 2.71175368 |
74 | Arterial tortuosity (HP:0005116) | 2.70963775 |
75 | Broad metatarsal (HP:0001783) | 2.70468744 |
76 | Distal arthrogryposis (HP:0005684) | 2.70250259 |
77 | Cervical subluxation (HP:0003308) | 2.68898989 |
78 | Wrist flexion contracture (HP:0001239) | 2.68646218 |
79 | Fragile skin (HP:0001030) | 2.68636148 |
80 | Metabolic acidosis (HP:0001942) | 2.67357908 |
81 | Systemic lupus erythematosus (HP:0002725) | 2.66980914 |
82 | Wormian bones (HP:0002645) | 2.65097014 |
83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.64314716 |
84 | Short 5th finger (HP:0009237) | 2.58897371 |
85 | Mesomelia (HP:0003027) | 2.56746489 |
86 | Wide anterior fontanel (HP:0000260) | 2.55187690 |
87 | Abnormality of purine metabolism (HP:0004352) | 2.54989192 |
88 | Mitral stenosis (HP:0001718) | 2.53511219 |
89 | Lethargy (HP:0001254) | 2.51198891 |
90 | Calcaneovalgus deformity (HP:0001848) | 2.50216518 |
91 | Deformed tarsal bones (HP:0008119) | 2.49613878 |
92 | Abnormal gallbladder morphology (HP:0012437) | 2.49446249 |
93 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.46845432 |
94 | Mild short stature (HP:0003502) | 2.45435467 |
95 | Vascular calcification (HP:0004934) | 2.43787323 |
96 | Aortic valve stenosis (HP:0001650) | 2.43592878 |
97 | Cholelithiasis (HP:0001081) | 2.43318626 |
98 | Acanthocytosis (HP:0001927) | 2.42968431 |
99 | Dicarboxylic aciduria (HP:0003215) | 2.42709310 |
100 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42709310 |
101 | Neonatal onset (HP:0003623) | 2.41936190 |
102 | Spondylolisthesis (HP:0003302) | 2.40499150 |
103 | Autoimmune thrombocytopenia (HP:0001973) | 2.40255018 |
104 | Spastic diplegia (HP:0001264) | 2.39684661 |
105 | Abnormal delivery (HP:0001787) | 2.38806154 |
106 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.36392845 |
107 | Dilatation of the ascending aorta (HP:0005111) | 2.35869877 |
108 | Bowel diverticulosis (HP:0005222) | 2.35649653 |
109 | Abnormal gallbladder physiology (HP:0012438) | 2.35523064 |
110 | Cholecystitis (HP:0001082) | 2.35523064 |
111 | Hypoglycemic seizures (HP:0002173) | 2.35243613 |
112 | Cerebral edema (HP:0002181) | 2.32861087 |
113 | Gout (HP:0001997) | 2.31907125 |
114 | Glomerulonephritis (HP:0000099) | 2.31422500 |
115 | Depressed nasal tip (HP:0000437) | 2.30757036 |
116 | Absent phalangeal crease (HP:0006109) | 2.28730366 |
117 | Amyloidosis (HP:0011034) | 2.28194621 |
118 | Irritability (HP:0000737) | 2.28153461 |
119 | Lip pit (HP:0100267) | 2.26755547 |
120 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26553294 |
121 | Redundant skin (HP:0001582) | 2.26261461 |
122 | Infantile muscular hypotonia (HP:0008947) | 2.24390141 |
123 | Cardiovascular calcification (HP:0011915) | 2.23704604 |
124 | Congenital hip dislocation (HP:0001374) | 2.22081542 |
125 | Delayed gross motor development (HP:0002194) | 2.21076744 |
126 | Hyperextensible skin (HP:0000974) | 2.20451034 |
127 | Natal tooth (HP:0000695) | 2.19693109 |
128 | Sensorimotor neuropathy (HP:0007141) | 2.16943850 |
129 | Brushfield spots (HP:0001088) | 2.15843575 |
130 | Decreased subcutaneous fat (HP:0001002) | 2.15822698 |
131 | Aortic regurgitation (HP:0001659) | 2.14964690 |
132 | Hypoventilation (HP:0002791) | 2.14317364 |
133 | Aplasia of the musculature (HP:0100854) | 2.14006194 |
134 | Abnormality of the calf musculature (HP:0001430) | 2.12493026 |
135 | Esophageal varix (HP:0002040) | 2.12379111 |
136 | Enlarged kidneys (HP:0000105) | 2.11287389 |
137 | Malnutrition (HP:0004395) | 2.10751183 |
138 | Breech presentation (HP:0001623) | 2.09224885 |
139 | Mitral valve prolapse (HP:0001634) | 2.09067737 |
140 | Gingival bleeding (HP:0000225) | 2.08318580 |
141 | Hip contracture (HP:0003273) | 2.08299971 |
142 | Pancreatitis (HP:0001733) | 2.06369932 |
143 | Status epilepticus (HP:0002133) | 2.05785671 |
144 | Menorrhagia (HP:0000132) | 2.03964540 |
145 | Hemorrhage of the eye (HP:0011885) | 2.03504178 |
146 | Increased corneal curvature (HP:0100692) | 2.02878809 |
147 | Keratoconus (HP:0000563) | 2.02878809 |
148 | Late onset (HP:0003584) | 2.02167380 |
149 | Limb-girdle muscle weakness (HP:0003325) | 2.01699909 |
150 | Abnormality of the gallbladder (HP:0005264) | 2.01025814 |
151 | Vomiting (HP:0002013) | 2.00119853 |
152 | Thrombophlebitis (HP:0004418) | 1.98952042 |
153 | Opisthotonus (HP:0002179) | 1.96877438 |
154 | Exercise-induced muscle cramps (HP:0003710) | 1.95846985 |
155 | Mitral regurgitation (HP:0001653) | 1.92877851 |
156 | Joint laxity (HP:0001388) | 1.90310875 |
157 | Increased connective tissue (HP:0009025) | 1.89919824 |
158 | Elbow flexion contracture (HP:0002987) | 1.89296652 |
159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88441222 |
160 | Rickets (HP:0002748) | 1.85211361 |
161 | Pterygium (HP:0001059) | 1.84879501 |
162 | Poikilocytosis (HP:0004447) | 1.83667429 |
163 | Abnormal cartilage morphology (HP:0002763) | 1.81630183 |
164 | Generalized aminoaciduria (HP:0002909) | 1.81615571 |
165 | Abnormal finger flexion creases (HP:0006143) | 1.81490187 |
166 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.81112073 |
167 | Hydroxyprolinuria (HP:0003080) | 1.80496668 |
168 | Abnormality of proline metabolism (HP:0010907) | 1.80496668 |
169 | Joint stiffness (HP:0001387) | 1.80454249 |
170 | Hyperventilation (HP:0002883) | 1.80200712 |
171 | Biconcave vertebral bodies (HP:0004586) | 1.79345839 |
172 | Hyperglycemia (HP:0003074) | 1.79041277 |
173 | Limited hip movement (HP:0008800) | 1.78726281 |
174 | Hypophosphatemic rickets (HP:0004912) | 1.77834324 |
175 | Overgrowth (HP:0001548) | 1.77150999 |
176 | Renal cortical cysts (HP:0000803) | 1.76871136 |
177 | Generalized amyotrophy (HP:0003700) | 1.76759224 |
178 | Morphological abnormality of the middle ear (HP:0008609) | 1.75730207 |
179 | Broad long bones (HP:0005622) | 1.75307550 |
180 | Abnormality of the neuromuscular junction (HP:0003398) | 1.75305279 |
181 | Fatigable weakness (HP:0003473) | 1.75305279 |
182 | Gowers sign (HP:0003391) | 1.73776110 |
183 | Abnormality of vitamin metabolism (HP:0100508) | 1.72770902 |
184 | Turricephaly (HP:0000262) | 1.71407254 |
185 | Alkalosis (HP:0001948) | 1.71389508 |
186 | Elevated hepatic transaminases (HP:0002910) | 1.71017734 |
187 | Acute hepatic failure (HP:0006554) | 1.70745693 |
188 | Vertebral compression fractures (HP:0002953) | 1.69957520 |
189 | Hypertriglyceridemia (HP:0002155) | 1.69526496 |
190 | Narrow palate (HP:0000189) | 1.68704146 |
191 | Neck muscle weakness (HP:0000467) | 1.67613205 |
192 | Ectopia lentis (HP:0001083) | 1.67169367 |
193 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66649607 |
194 | Exercise-induced myalgia (HP:0003738) | 1.64905783 |
195 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.64668224 |
196 | Lipoatrophy (HP:0100578) | 1.63390222 |
197 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.62105491 |
198 | Mucopolysacchariduria (HP:0008155) | 1.62105491 |
199 | Tarsal synostosis (HP:0008368) | 1.61514902 |
200 | Broad ribs (HP:0000885) | 1.61274096 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.31209382 |
2 | SIK1 | 4.89372474 |
3 | STK24 | 4.54411103 |
4 | WNK4 | 4.21340151 |
5 | FGFR4 | 4.05726876 |
6 | ERN1 | 3.94294716 |
7 | MYLK | 3.74118498 |
8 | CCNB1 | 3.45755620 |
9 | STK39 | 3.44272173 |
10 | MAP2K4 | 2.86341695 |
11 | LIMK1 | 2.86010737 |
12 | INSRR | 2.84077709 |
13 | ERBB4 | 2.83360513 |
14 | MUSK | 2.79899002 |
15 | TTN | 2.58410841 |
16 | ILK | 2.47026807 |
17 | OBSCN | 2.41144171 |
18 | TAOK3 | 2.34061485 |
19 | DDR2 | 2.24548761 |
20 | DAPK2 | 2.20463506 |
21 | MST1R | 2.16846461 |
22 | LATS1 | 2.07988344 |
23 | PKN2 | 1.84459464 |
24 | FGFR2 | 1.82832787 |
25 | MAPKAPK3 | 1.80869156 |
26 | TRIB3 | 1.74199962 |
27 | MAPK11 | 1.72355508 |
28 | TRPM7 | 1.69056807 |
29 | PIK3CG | 1.67360981 |
30 | PAK2 | 1.64660590 |
31 | MOS | 1.61644372 |
32 | JAK3 | 1.53828343 |
33 | WNK1 | 1.51872788 |
34 | FRK | 1.50909492 |
35 | EPHA3 | 1.46438204 |
36 | FLT3 | 1.45473797 |
37 | CAMKK2 | 1.44393013 |
38 | EPHA4 | 1.40643555 |
39 | PTK6 | 1.40512906 |
40 | EPHB2 | 1.39371061 |
41 | PTK2B | 1.36705226 |
42 | TESK1 | 1.34891523 |
43 | ADRBK1 | 1.31948534 |
44 | CAMK1D | 1.30971148 |
45 | TYK2 | 1.26713265 |
46 | ABL2 | 1.24145472 |
47 | ADRBK2 | 1.22733385 |
48 | PAK6 | 1.22468033 |
49 | CAMK1 | 1.22015382 |
50 | MAP3K7 | 1.20668372 |
51 | ZAK | 1.19771026 |
52 | MAP3K2 | 1.19264499 |
53 | NEK9 | 1.16363632 |
54 | JAK2 | 1.15225481 |
55 | PHKG1 | 1.10609782 |
56 | PHKG2 | 1.10609782 |
57 | GRK1 | 1.10145747 |
58 | ROCK1 | 1.07008031 |
59 | PRKAA2 | 1.05852732 |
60 | MARK1 | 1.00861149 |
61 | RIPK1 | 0.99421352 |
62 | PRKD2 | 0.99032548 |
63 | PINK1 | 0.98286788 |
64 | PRKCZ | 0.97923770 |
65 | JAK1 | 0.96418231 |
66 | KIT | 0.95785307 |
67 | CAMK1G | 0.93327437 |
68 | MAPK4 | 0.90896002 |
69 | ERBB2 | 0.89918743 |
70 | GRK7 | 0.88842814 |
71 | LATS2 | 0.88518274 |
72 | EEF2K | 0.88437858 |
73 | SGK3 | 0.86031702 |
74 | RPS6KA6 | 0.84361028 |
75 | MAPK12 | 0.83867252 |
76 | MET | 0.81669298 |
77 | MAP4K2 | 0.81611217 |
78 | CDK6 | 0.81231137 |
79 | TNIK | 0.81005392 |
80 | CHEK2 | 0.80788621 |
81 | PLK2 | 0.80341546 |
82 | RPS6KC1 | 0.77791438 |
83 | RPS6KL1 | 0.77791438 |
84 | GRK6 | 0.77079099 |
85 | KDR | 0.76608448 |
86 | CAMK2G | 0.76384229 |
87 | STK38L | 0.75562067 |
88 | PRKACG | 0.74814933 |
89 | MAPK7 | 0.74025995 |
90 | MAP3K4 | 0.72777380 |
91 | PRKG2 | 0.72338654 |
92 | PIK3CA | 0.71768510 |
93 | PRKCG | 0.71476540 |
94 | CAMKK1 | 0.69203557 |
95 | PDGFRB | 0.67121305 |
96 | PTK2 | 0.67071575 |
97 | SGK2 | 0.66611746 |
98 | PDGFRA | 0.66165710 |
99 | PRKAA1 | 0.65406685 |
100 | GSK3A | 0.65107064 |
101 | PRKCE | 0.64786771 |
102 | RET | 0.62928108 |
103 | EPHB1 | 0.62503174 |
104 | MAP2K6 | 0.61298181 |
105 | SIK2 | 0.60432635 |
106 | PDPK1 | 0.59340909 |
107 | SGK223 | 0.58291201 |
108 | SGK494 | 0.58291201 |
109 | MAP2K1 | 0.57517071 |
110 | PNCK | 0.57345002 |
111 | ERBB3 | 0.56225138 |
112 | FGFR3 | 0.55831356 |
113 | MAP3K11 | 0.55690435 |
114 | DAPK3 | 0.55253391 |
115 | FER | 0.55171829 |
116 | ROCK2 | 0.54491948 |
117 | CASK | 0.54447469 |
118 | BMPR1B | 0.54149163 |
119 | MAPK13 | 0.53743410 |
120 | DYRK1B | 0.53123041 |
121 | MAP2K3 | 0.51548457 |
122 | MAP3K10 | 0.50749141 |
123 | MAPK15 | 0.50592712 |
124 | RPS6KA2 | 0.50428929 |
125 | TBK1 | 0.50351329 |
126 | PAK3 | 0.49757654 |
127 | GRK5 | 0.49450765 |
128 | IGF1R | 0.49250078 |
129 | PRKCQ | 0.49012030 |
130 | CDC42BPA | 0.48327647 |
131 | TIE1 | 0.46894297 |
132 | CAMK2A | 0.46778169 |
133 | FGFR1 | 0.45376926 |
134 | AKT3 | 0.45063627 |
135 | CAMK4 | 0.44812560 |
136 | TAOK2 | 0.43485658 |
137 | MELK | 0.42370605 |
138 | MAP3K14 | 0.41394519 |
139 | CSNK1G1 | 0.41299445 |
140 | MAP3K3 | 0.40962103 |
141 | NEK2 | 0.40783200 |
142 | MAP2K7 | 0.39680062 |
143 | CAMK2D | 0.39523810 |
144 | MAP3K5 | 0.38923043 |
145 | PAK1 | 0.38458287 |
146 | CSK | 0.38444114 |
147 | DMPK | 0.37880153 |
148 | TGFBR1 | 0.37629679 |
149 | NTRK2 | 0.37179045 |
150 | DAPK1 | 0.36956691 |
151 | CSNK1G2 | 0.36954288 |
152 | IRAK2 | 0.36775627 |
153 | PKN1 | 0.36603174 |
154 | PDK1 | 0.36355712 |
155 | NTRK1 | 0.35739791 |
156 | CDK9 | 0.34306049 |
157 | PRKCH | 0.33905548 |
158 | MTOR | 0.33406633 |
159 | PRKG1 | 0.32666741 |
160 | MAP3K1 | 0.32273321 |
161 | STK38 | 0.32201839 |
162 | PRKCA | 0.32089470 |
163 | LMTK2 | 0.31273290 |
164 | TGFBR2 | 0.29417525 |
165 | EGFR | 0.29266481 |
166 | BMX | 0.28937077 |
167 | ABL1 | 0.28682414 |
168 | MINK1 | 0.28537074 |
169 | DYRK3 | 0.27500050 |
170 | NUAK1 | 0.27348973 |
171 | CDK8 | 0.26175482 |
172 | STK16 | 0.24792861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.62148283 |
2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.20792895 |
3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.74737236 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74605308 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45435896 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34162787 |
7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.30566906 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.12999685 |
9 | Focal adhesion_Homo sapiens_hsa04510 | 2.88086970 |
10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.87722622 |
11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80417142 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68648171 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67400989 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60692501 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.52242595 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47428418 |
17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45169789 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37508126 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19838772 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18393403 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09737948 |
22 | Peroxisome_Homo sapiens_hsa04146 | 2.06522430 |
23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93927561 |
24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93793688 |
25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93488900 |
26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92625921 |
27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88996638 |
28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.85540682 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84820786 |
30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80865508 |
31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77763284 |
32 | Phototransduction_Homo sapiens_hsa04744 | 1.76901016 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72627665 |
34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71612778 |
35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71609600 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70316201 |
37 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.70135198 |
38 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.68998404 |
39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68862683 |
40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62761614 |
41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61179829 |
42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.59116664 |
43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.58644021 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57946714 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.57464512 |
46 | Bile secretion_Homo sapiens_hsa04976 | 1.56783447 |
47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.54001681 |
48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48730999 |
49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47201229 |
50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.46912244 |
51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46610679 |
52 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.45245312 |
53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44926110 |
54 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.44655053 |
55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40571766 |
56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40393489 |
57 | Platelet activation_Homo sapiens_hsa04611 | 1.37281879 |
58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35599750 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34528801 |
60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.31427862 |
61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30611555 |
62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27533255 |
63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.26838587 |
64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26090955 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25781995 |
66 | Melanoma_Homo sapiens_hsa05218 | 1.25045103 |
67 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24905125 |
68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24344343 |
69 | Circadian entrainment_Homo sapiens_hsa04713 | 1.22602561 |
70 | Gap junction_Homo sapiens_hsa04540 | 1.19911258 |
71 | ABC transporters_Homo sapiens_hsa02010 | 1.17513672 |
72 | Salivary secretion_Homo sapiens_hsa04970 | 1.16033657 |
73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15585239 |
74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14108103 |
75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11427296 |
76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11088572 |
77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09981374 |
78 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08661840 |
79 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07676636 |
80 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07392888 |
81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04416177 |
82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.03235449 |
83 | Adherens junction_Homo sapiens_hsa04520 | 0.99542509 |
84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97194469 |
85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93846600 |
86 | Long-term depression_Homo sapiens_hsa04730 | 0.93054103 |
87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92425485 |
88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90985709 |
89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.90697568 |
90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88627605 |
91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88264575 |
92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88240423 |
93 | Melanogenesis_Homo sapiens_hsa04916 | 0.87985143 |
94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87671031 |
95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86721009 |
96 | Malaria_Homo sapiens_hsa05144 | 0.85451483 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.85283823 |
98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85160749 |
99 | Lysine degradation_Homo sapiens_hsa00310 | 0.79608408 |
100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79433340 |
101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79256916 |
102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78757449 |
103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75445650 |
104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74684271 |
105 | Axon guidance_Homo sapiens_hsa04360 | 0.73123323 |
106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70894431 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70577280 |
108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70404950 |
109 | Tight junction_Homo sapiens_hsa04530 | 0.69924034 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.69838292 |
111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68103960 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66462432 |
113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65484888 |
114 | Renin secretion_Homo sapiens_hsa04924 | 0.65329476 |
115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64529846 |
116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60998381 |
117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60027365 |
118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58792029 |
119 | Phagosome_Homo sapiens_hsa04145 | 0.54665223 |
120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54054749 |
121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53671225 |
122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53481359 |
123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53279851 |
124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52593671 |
125 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51822203 |
126 | Pertussis_Homo sapiens_hsa05133 | 0.50715782 |
127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50664253 |
128 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49806581 |
129 | Taste transduction_Homo sapiens_hsa04742 | 0.49525557 |
130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49135651 |
131 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48801492 |
132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47393012 |
133 | Shigellosis_Homo sapiens_hsa05131 | 0.46674070 |
134 | Morphine addiction_Homo sapiens_hsa05032 | 0.46443513 |
135 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45695503 |
136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43661376 |
137 | Prion diseases_Homo sapiens_hsa05020 | 0.42740985 |
138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41291376 |
139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40808220 |
140 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40761588 |
141 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40255623 |
142 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40082209 |
143 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37933267 |
144 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37856880 |
145 | Insulin secretion_Homo sapiens_hsa04911 | 0.36446026 |
146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35278461 |
147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27783037 |
148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27250504 |
149 | Insulin resistance_Homo sapiens_hsa04931 | 0.26221161 |
150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21905520 |
151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17236650 |
152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16883265 |
153 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16844401 |
154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14129759 |
155 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13620138 |
156 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13273936 |
157 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.13244621 |
158 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08228932 |
159 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2467690 |
160 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2245336 |
161 | Hepatitis C_Homo sapiens_hsa05160 | -0.2150112 |
162 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2060147 |
163 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1969868 |
164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1954283 |
165 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1950267 |
166 | Amoebiasis_Homo sapiens_hsa05146 | -0.1857613 |
167 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1848712 |
168 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1771237 |
169 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1745441 |
170 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1593155 |
171 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1570202 |
172 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1473087 |
173 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1353374 |
174 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1334556 |
175 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1050982 |
176 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0748996 |
177 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0372230 |
178 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0226087 |